BEGIN:VCALENDAR PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN VERSION:2.0 BEGIN:VEVENT DESCRIPTION:Formerly the Women's Health Innovation Summit\, WHIS brings to gether the entire women's health ecosystem and incorporates previous FemT ech and Reproductive Health events. It consolidates multi-sector efforts to accelerate industry-wide solutions across women's health\, mirroring a critical moment of convergence in women's health innovation.\n\nWHIS 202 5 unites a diverse range of stakeholders: start-ups and scale ups\, inves tors\, pharmaceutical and biotech multinationals\, payers\, public sector and regulatory bodies\, with service providers like CROs\, legal advisor s\, and consultancy groups. The event's mission is clear: tackle persiste nt disparities by fostering commercial\, regulatory\, clinical\, and tech nological insight sharing across a comprehensive women's health agenda.\n \nWhat's On and Who's Talking. Innovation Showcase: At the beating heart of WHIS\, 20 trailblazing start ups will pitch across two categories - Di gital Health and FemTech and Therapeutics and Med Devices - to an audienc e of 800+ decision makers \;. WHIS Innovators Academy: New in 2025\, this pre-event deep dive day equips emerging companies with mission criti cal skills\, from IP\, branding\, and reimbursement\, to regulatory fast tracking\, market strategy\, and trial recruitment \;. Keynotes\, Pan els and Presentations: Accelerate growth\, drive adoption\, and deliver m easurable outcomes across the entire care spectrum by updating your strat egy in line with the latest insights from industry leaders. From unlockin g funding pathways and payer strategies\, to navigating regulatory hurdle s and advancing clinical validation\, these sessions are designed to help you supercharge your progress.. Structured 1:2:1 Networking: Forge comme rcial collaborations from seed to global distribution attendees by pre-sc heduling meetings with the partner that matter most to you.\n\nWhy It Mat ters to the Healthcare CommunityWHIS addresses long standing critical inv estment signals: reproductive health markets\, such as endometriosis mana gement\, are now projected to reach into the hundreds of billions annuall y\, a figure amplified by unmet needs and underinvestment. For founders a nd investors\, it offers both runway and runway acceleration: showcase op portunities\, high level investor and payer access\, coupled with actiona ble insights on pathways to scale\, reimbursement\, and regulatory naviga tion.\n\nWho Attends and Why Their Voice Counts. Start ups and SMEs: Will find a launchpad for visibility\, partnerships\, and funding. The dedica ted Innovation Showcase is a proven platform for finalists to attract inv estment. \;. Payers and Providers: Gain early sight of clinical and d igital tools that can improve women's health outcomes while reining in co st drivers\, particularly in maternal and chronic care sectors.. Big Phar ma and Biotech: Engage with emerging technologies and pipeline prospects that complement your portfolios and explore acquisition and licensing pat hways.. Service Providers and Policymakers: Exchange regulatory\, reimbur sement\, legal\, and market access strategies that support scaling throug hout lifespan-focused care.\n\nWHIS 2025 marks a pivotal chapter in women 's health. By weaving together digital\, clinical\, commercial\, and regu latory threads into one cohesive platform\, it offers a rare opportunity for women's health leaders to not only showcase innovations but to implem ent them and scale them as we deliver the future of health for women.&nbs p\;\n\nURL:Tickets: \;https://go.evvnt.com/3100983-0?pid=185\n\nPrice s:Tier 1 - Academics\, NPOs\, Payers\, Healthcare Providers and Clinics A dvocacy Groups: USD 699.00\,Tier 2 - Start Ups (Pre-Revenue) and Start Up s (Seed - Series A): USD 899.00\,Tier 3 - Small and Medium-Sized Enterpri ses (Revenue Generating\, Series B+) and Investors (Angel\, VC): USD 1299 .00\,Tier 4 - Pharmaceutical Companies\, Med Device Companies\, Multinati onal Consumer Brands\, Retailers\, Service Providers\, including Consulta nts\, CROs\, Marketing Agencies\, Law Firms and Investors (PE\, Banks\, F inancial Institutions): USD 2899.00\n\nSpeakers: \;Dianne Balon\, SVP of Government\, BLUE CROSS\, Tamara Orlova\, Chief Financial Officer\, FLO HEALTH\, Roohi Jeelani\, Chief Growth Officer\, KINDBODY\, Katie Ryan\, Se nior Innovation Strategist\, HUMANA\, Maxine Carrington\, Chief People Offi cer\, NORTHWELL HEALTH\, Lynn Mason\, Chief Executive Officer\, IVI RMA GLO BAL\, Lucy Perez\, Senior Partner - Life Sciences\, MCKINSEY and COMPANY\ , Neel Shah\, Chief Medical Officer\, MAVEN CLINIC\n\nCategory: \;Confe rences | Health\n\nDate and Time: \;4th November 2025 at 8:00 am to 6 th November 2025 at 5:00 pm\n\nVenue details: \;The Westin Copley Pla ce\, Boston\, 10 Huntington Avenue\, Boston\, Massachusetts\, 02116\, Uni ted States\n DTEND:20251106T170000 DTSTAMP:20260513T003006Z DTSTART:20251104T080000 LOCATION:The Westin Copley Place\, Boston\, 10\, Huntington Avenue\, Bosto n\, Massachusetts\, 02116\, SEQUENCE:0 SUMMARY:Formerly the Women's Health Innovation Summit\, WHIS brings togeth er the entire women's health ecosystem and incorporates previous FemTech and Repro... UID:c08255f9-b764-4b2c-a64e-930c4da75262 END:VEVENT END:VCALENDAR